Literature DB >> 12965237

The Kir6.1-protein, a pore-forming subunit of ATP-sensitive potassium channels, is prominently expressed by giant cholinergic interneurons in the striatum of the rat brain.

Achim Thomzig1, Harald Prüss, Rüdiger W Veh.   

Abstract

ATP-sensitive potassium channels comprise a complex of two structurally different proteins: a member of the inwardly rectifying Kir6 family (Kir6.1 or Kir6.2) and a sulfonylurea receptor (SUR1 or SUR2). Their regulation by intracellular ADP/ATP-concentrations and through various pharmacological agents has profound implications for the excitability of cells and, in the case of neurons, for neurotransmitter release. We previously showed that in rat brain, the Kir6.1 subunit is predominantly expressed in astrocytes in contrast to the Kir6.2 subunit, which is exclusively expressed in neurons. In this report we show, that in addition to the astrocytic expression, the Kir6.1 protein is also found in a small subset of neurons in distinct areas of the brain, like the hypothalamic supraoptic and paraventricular nuclei and the striatum. The Kir6.1-positive neurons in the striatum could be characterized as cholinergic interneurones, verified by immunofluorescence double staining. This complete colocalization of the Kir6.1 subunit in cholinergic interneurons is interesting with respect to the pharmacological potential of these channels. A selective modulation of the Kir6.1 subunit in the cholinergic striatal interneurons may eventually be of therapeutic value for the treatment of Parkinson's disease.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12965237     DOI: 10.1016/s0006-8993(03)03222-0

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  9 in total

Review 1.  ATP-sensitive potassium channels: novel potential roles in Parkinson's disease.

Authors:  Jie Zeng; Gang Wang; Sheng-Di Chen
Journal:  Neurosci Bull       Date:  2007-11       Impact factor: 5.203

2.  The neuroprotection of hydrogen sulfide against MPTP-induced dopaminergic neuron degeneration involves uncoupling protein 2 rather than ATP-sensitive potassium channels.

Authors:  Ming Lu; Fang-Fang Zhao; Juan-Juan Tang; Cun-Jin Su; Yi Fan; Jian-Hua Ding; Jin-Song Bian; Gang Hu
Journal:  Antioxid Redox Signal       Date:  2012-04-20       Impact factor: 8.401

3.  Subsecond regulation of striatal dopamine release by pre-synaptic KATP channels.

Authors:  Jyoti C Patel; Paul Witkovsky; William A Coetzee; Margaret E Rice
Journal:  J Neurochem       Date:  2011-08-04       Impact factor: 5.372

Review 4.  Classification of H₂O₂as a neuromodulator that regulates striatal dopamine release on a subsecond time scale.

Authors:  Jyoti C Patel; Margaret E Rice
Journal:  ACS Chem Neurosci       Date:  2012-11-08       Impact factor: 4.418

5.  Electrophysiological and molecular characterization of the inward rectifier in juxtaglomerular cells from rat kidney.

Authors:  Anke Leichtle; Ulrich Rauch; Margitta Albinus; Peter Benöhr; Hubert Kalbacher; Andreas F Mack; Rüdiger W Veh; Ulrich Quast; Ulrich Russ
Journal:  J Physiol       Date:  2004-07-29       Impact factor: 5.182

Review 6.  Brain Iron Metabolism Dysfunction in Parkinson's Disease.

Authors:  Hong Jiang; Jun Wang; Jack Rogers; Junxia Xie
Journal:  Mol Neurobiol       Date:  2016-04-02       Impact factor: 5.590

7.  Supraoptic oxytocin and vasopressin neurons function as glucose and metabolic sensors.

Authors:  Zhilin Song; Barry E Levin; Wanida Stevens; Celia D Sladek
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-01-29       Impact factor: 3.619

Review 8.  Astroglial Modulation of Hydromineral Balance and Cerebral Edema.

Authors:  Yu-Feng Wang; Vladimir Parpura
Journal:  Front Mol Neurosci       Date:  2018-06-12       Impact factor: 5.639

9.  Induced Expression of kir6.2 in A1 Astrocytes Propagates Inflammatory Neurodegeneration via Drp1-dependent Mitochondrial Fission.

Authors:  Nanshan Song; Hong Zhu; Rong Xu; Jiaqi Liu; Yinquan Fang; Jing Zhang; Jianhua Ding; Gang Hu; Ming Lu
Journal:  Front Pharmacol       Date:  2021-01-28       Impact factor: 5.810

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.